Otherwise, Kuang et al. found monocytes activated by tumors strongly express programmed cell death ligand 1 (PD‐L1) and effectively suppressed tumor‐specific T cell immunity in HCC in vivo.139. This evidence concerns the gene CD274 and hepatocellular carcinoma.